VG Acquisition Corp. (NYSE:VGAC) announced in a press release that its shareholders approved its combination with genetic researcher 23andMe at a special meeting held earlier today.
The SPAC did not disclose redemption figures, but noted that more than 87% of the votes cast were in favor of the approval of the merger agreement. Shareholders also voted overwhelmingly to approve the other proposals presented at the meeting.
VG opened at $10.01 on the day of its redemption deadline June 8, just under its estimated $10.02 pro rata trust value, but its shares have traded above trust value ever since. Rumors of a good vote appear to have already rippled out in the market as the stock rose 8.12% to $10.99 on the day.
The transaction is now expected to close on June 16 with the combined entity’s shares and warrants commencing trading on the Nasdaq under the symbols “ME” and “MEUSW” on June 17, respectively.
VG and 23AndMe initially announced the $3.46 billion deal on February 4. 23andMe provides consumers information about their ancestry and gene-based health factors through DNA tests and has leveraged its platform for broader genetic research.
VG’s shareholder approval marks the tenth successful SPAC vote since June 1st.
ADVISORS
- Citi is serving as lead financial advisor, capital markets advisor and placement agent to 23andMe
- Morgan, Lewis & Bockius LLP is serving as legal counsel to 23andMe
- Credit Suisse acted as lead financial advisor, capital markets advisor and placement agent to VG Acquisition Corp
- LionTree Advisors acted as financial advisor and Davis Polk & Wardwell LLP is serving as legal counsel to VG Acquisition Corp
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...
Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...
Despite a week of general pull-backs in the market, fintech firm Ibotta (NYSE:IBTA) nonetheless took the dive and had a good week debuting via a traditional IPO in the choppy waters. The company, which provides app-based consumer cashback discounts on purchases, priced its IPO at $88, above its proposed range of $76 to $84, and...